emd 53998 has been researched along with Cardiomyopathy, Congestive in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, T; Campbell, KS; Hessel, AL; Iwamoto, H; Lewis, CTA; Ochala, J; Pyle, WG | 1 |
| Copeland, O; Ferenczi, MA; Marston, SB; Messer, AE; Song, W; Vikhorev, PG; Wilkinson, R | 1 |
| Chiesi, M; Depersin, H; Grüninger, S; Hasenfuss, G; Herzig, JW; Holubarsch, C; Kubalek, R; Leutert, T; Pieske, B; Pioch, K; Wenk, P | 1 |
| Clarke, SB; Drake-Holland, AJ; Hynd, J; Lee, JA; Noble, MI | 1 |
| Holubarsch, C; Just, H; Lüdemann, J; Pieske, B; Posival, H; Ruf, T; Schmidt-Schweda, S; Schulte-Baukloh, H; Wiessner, S | 1 |
| Brixius, K; Reicke, S; Reuter, H; Schwinger, RH | 1 |
6 other study(ies) available for emd 53998 and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Predominant myosin superrelaxed state in canine myocardium with naturally occurring dilated cardiomyopathy.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Dilated; Dogs; Humans; Myocardium; Myosins | 2023 |
The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.
Topics: Actins; Animals; Calcium; Cardiomyopathy, Dilated; Carrier Proteins; Cyclic AMP-Dependent Protein Kinases; Female; Male; Mice; Mice, Transgenic; Muscle Contraction; Mutation; Myofibrils; Phosphorylation; Propranolol; Quinolines; Sarcomeres; Thiadiazines; Troponin I | 2014 |
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2
Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes | 1996 |
Beneficial effect of the calcium-sensitizing drug EMD 57033 in a canine model of dilated heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dogs; Echocardiography, Transesophageal; Quinolines; Statistics, Nonparametric; Thiadiazines; Ventricular Pressure | 1997 |
Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation.
Topics: Adolescent; Adult; Aged; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Rate; Humans; Isoproterenol; Middle Aged; Myocardial Contraction; Ouabain; Quinolines; Regression Analysis; Stimulation, Chemical; Thiadiazines; Ventricular Function, Left | 1998 |
Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Topics: Azocines; Calcium; Calcium Channels; Cardiomyopathy, Dilated; Cardiotonic Agents; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Humans; Myocardial Contraction; Quinolines; Thiadiazines | 2002 |